Alzheimer's buddy program pairs patients, students

March 4, 2014 by Lindsey Tanner

A retired Chicago physician and educator is getting a bittersweet last chance to teach about medicine. This time Dr. Dan Winship is the subject.

He's 80 and in the early stages of Alzheimer's disease. Winship is among patients in a buddy program that gives a close-up look at a disease they'll likely see often in their careers.

Alzheimer's affects millions nationwide and the numbers are expected to keep rising.

Northwestern University is among a handful of medical schools that run Alzheimer buddy programs. Students and socialize often and get to know each other during the school year.

Winship is paired with first-year med student Jared Worthington. He says the best part is just getting to hang out together.

Explore further: Some medical schools offering accelerated training

Related Stories

Some medical schools offering accelerated training

January 22, 2014
(HealthDay)—Some medical schools are offering an accelerated three-year program, according to a report from Kaiser Health News.

Potential biomarkers for the diagnosis of Alzheimer's disease

January 31, 2014
Researchers identify abnormal expression of genes, resulting from DNA relaxation, that can be detected in the brain and blood of Alzheimer's patients.

Need for dementia caregivers grows as boomers age

December 17, 2013
World leaders set a goal for a cure or treatment for dementia by 2025 at the recent G8 summit in London.

Researchers discover an epigenetic lesion in the hippocampus of Alzheimer's

January 21, 2014
Alzheimer's disease can reach epidemic range in the coming decades, by the increasing average age of society. There are two key issues for Alzheimer's disease: there is currently no effective treatment and it has been described ...

Two parents with Alzheimer's disease? Disease may show up decades early on brain scans

February 12, 2014
People who are dementia-free but have two parents with Alzheimer's disease may show signs of the disease on brain scans decades before symptoms appear, according to a new study published in the February 12, 2014, online issue ...

New risk gene illuminates Alzheimer's disease

February 25, 2014
A team of international scientists, including a researcher from Simon Fraser University, has isolated a gene thought to play a causal role in the development of Alzheimer's disease. The Proceedings of the National Academy ...

Recommended for you

Alzheimer's disease: Neuronal loss very limited

January 17, 2018
Frequently encountered in the elderly, Alzheimer's is considered a neurodegenerative disease, which means that it is accompanied by a significant, progressive loss of neurons and their nerve endings, or synapses. A joint ...

Anxiety: An early indicator of Alzheimer's disease?

January 12, 2018
A new study suggests an association between elevated amyloid beta levels and the worsening of anxiety symptoms. The findings support the hypothesis that neuropsychiatric symptoms could represent the early manifestation of ...

One of the most promising drugs for Alzheimer's disease fails in clinical trials

January 11, 2018
To the roughly 400 clinical trials that have tested some experimental treatment for Alzheimer's disease and come up short, we can now add three more.

Different disease types associated with distinct amyloid-beta prion strains found in Alzheimer's patients

January 9, 2018
An international team of researchers has found different disease type associations with distinct amyloid-beta prion strains in the brains of dead Alzheimer's patients. In their paper published in Proceedings of the National ...

Advances in brain imaging settle debate over spread of key protein in Alzheimer's

January 5, 2018
Recent advances in brain imaging have enabled scientists to show for the first time that a key protein which causes nerve cell death spreads throughout the brain in Alzheimer's disease - and hence that blocking its spread ...

Molecular mechanism behind HIV-associated dementia revealed

January 5, 2018
For the first time, scientists have identified and inhibited a molecular process that can lead to neurodegeneration in patients with HIV, according to a Northwestern Medicine study published in Nature Communications.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.